GHRH and susceptibility to pneumonia measurement: Moreover, since the synthetic GHRH agonists have a longer serum half-life than the hypothalamic GHRH hormone itself [68], they can deliver a more potent signal for damaged lungs and provide the basis for novel treatment options for pneumonia and acute lung injury.